Healthcare provider profile · identity verified

Amber N Kemp, ARNP

Nurse Practitioner · DUBUQUE, IA · NPI 1255681029

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	406	95
Levothyroxine Sodium	Levothyroxine Sodium	373	63
Omeprazole	Omeprazole	328	74
Simvastatin	Simvastatin	315	72
Gabapentin	Gabapentin	244	54
Lisinopril	Lisinopril	244	57
Furosemide	Furosemide	240	47
Amlodipine Besylate	Amlodipine Besylate	196	49
Losartan Potassium	Losartan Potassium	175	42
Potassium Chloride	Potassium Chloride	168	34
Montelukast Sodium	Montelukast Sodium	152	32
Atenolol	Atenolol	139	32
Enalapril Maleate	Enalapril Maleate	132	35
Citalopram Hbr	Citalopram Hydrobromide	126	29
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	124	31
Metoprolol Succinate	Metoprolol Succinate	122	22
Tramadol Hcl	Tramadol Hcl	119	27
Sertraline Hcl	Sertraline Hcl	112	16
Pravastatin Sodium	Pravastatin Sodium	108	25
Escitalopram Oxalate	Escitalopram Oxalate	104	15
Eliquis	Apixaban	100	11
Fluticasone Propionate	Fluticasone Propionate	93	38
Alendronate Sodium	Alendronate Sodium	90	27
Metformin Hcl	Metformin Hcl	90	29
Hydrochlorothiazide	Hydrochlorothiazide	84	22
Fluoxetine Hcl	Fluoxetine Hcl	82	16
Pantoprazole Sodium	Pantoprazole Sodium	82	21
Metformin Hcl Er	Metformin Hcl	81	22
Trazodone Hcl	Trazodone Hcl	81	16
Xarelto	Rivaroxaban	77	suppressed
Donepezil Hcl	Donepezil Hcl	76	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	28
Spironolactone	Spironolactone	70	17
Lorazepam	Lorazepam	68	25
Allopurinol	Allopurinol	65	16
Rosuvastatin Calcium	Rosuvastatin Calcium	65	22
Famotidine	Famotidine	64	13
Metoprolol Tartrate	Metoprolol Tartrate	63	16
Duloxetine Hcl	Duloxetine Hcl	59	suppressed
Warfarin Sodium	Warfarin Sodium	54	suppressed
Alprazolam	Alprazolam	53	19
Carbidopa-Levodopa	Carbidopa/Levodopa	53	suppressed
Clopidogrel	Clopidogrel Bisulfate	53	suppressed
Prednisone	Prednisone	50	36
Sumatriptan Succinate	Sumatriptan Succinate	48	suppressed
Bupropion Xl	Bupropion Hcl	47	suppressed
Glimepiride	Glimepiride	42	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	33
Tamsulosin Hcl	Tamsulosin Hcl	42	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	41	15
Jardiance	Empagliflozin	40	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Meloxicam	Meloxicam	38	suppressed
Memantine Hcl	Memantine Hcl	38	suppressed
Baclofen	Baclofen	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Sucralfate	Sucralfate	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Entresto	Sacubitril/Valsartan	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Cephalexin	Cephalexin	26	17
Estradiol	Estradiol	26	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	15
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Azithromycin	Azithromycin	23	20
Ozempic	Semaglutide	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Carvedilol	Carvedilol	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Nystatin	Nystatin	21	11
Nystop	Nystatin	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	11
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	17	12
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Digoxin	Digoxin	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Denta 5000 Plus	Fluoride (Sodium)	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	11
Fluticasone Propionate Hfa	Fluticasone Propionate	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Diazepam	Diazepam	14	suppressed
Novolin N	Insulin Nph Human Isophane	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Clozapine	Clozapine	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error